By contrast, Black patients, those with squamous cell carcinoma, the presence of an HER2 mutation, and brain or bone metastasis were associated with poorer OS (p-value <0.01, 0.023, 0.028, 0.034, and 0.039, respectively). This evidence concerns the gene ERBB2 and bone metastasis.